MEHCQ — Chrome Holding Co Share News
0.000.00%
Last trade - 00:00- $96.60m
- $81.77m
- $189.90m
23andMe cuts 40% of its workforce, discontinues all therapy programs (updated)
23andMe cuts 40% of its workforce
Brief: 23AndMe Regains Compliance With Nasdaq Listing Requirements
Brief: 23andMe Appoints Three New Independent Directors To Board
Brief: Anne Wojcicki Says No Longer Open To Considering Third Party Takeover Proposals For 23AndMe
23andMe CEO Wojcicki no longer open to third-party takeover proposals, filing shows
Column: Could 23andMe $30 million data breach settlement get derailed by mass arbitration?
23andMe deal should never be cloned
Press Digest: Wall Street Journal - Sept 19
Brief: 23andMe Holding - Got Deficiency Letter From Nasdaq, Notifying That Co Not In Compliance With Nasdaq Listing Rule 5605
U.S. STOCKS ON THE MOVE-Powerfleet, NMI, Vivos Therapeutics
U.S. STOCKS ON THE MOVE-Intuitive Machine, VF, 23andMe Holding
Brief: Independent Directors Of 23AndMe Resign From Board
23andMe independent directors quit board over unsatisfactory buyout plan from CEO
Brief: 23AndMe Therapeutics Announces Phase 2 Results For Two Additional Cancer Cohorts And Correlative Biomarker Data From 23Me-00610 Study
Brief: 23Andme Therapeutics Announces Positive In Vivo Results For 23Me-01473, A Dual-Mechanism Ulbp6-Targeting Antibody Currently In A Phase 1 Trial
23andMe settles data breach lawsuit for $30 million
Brief: Anne Wojcicki Wojcicki Would Be Open To Considering Third Party Takeover Proposal For 23andMe
23andMe CEO Wojcicki open to third-party takeover proposals for firm, filing shows